The practicalities of using tissue slices as preclinical organotypic breast cancer models

Deborah L. Holliday, Marcus A. Moss, Steven Pollock, Sally Lane, Abeer M. Shaaban, Rebecca Millican-Slater, Claire Nash, Andrew M. Hanby, Valerie Speirs

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Models considering breast cancer complexity cannot be easily or accurately replicated in routine cell line or animal models. We aimed to evaluate the practicality of organotypic tissue slice culture in breast cancer. Following ethical approval, 250 µm thick sections from surplus breast tumours (n=10) were prepared using a vibrating blade microtome. Triplicate tissue slices were placed in 6-well plates and cultured for up to 7 days ± tamoxifen (1 nM) or doxorubicin (1 µM). Tissue slices were fixed and embedded before sectioning for morphological evaluation and immunohistochemistry. H&E showed good preservation of tissue morphology. Collagen production was evident. Biomarkers of proliferation and apoptosis could be evaluated using immunohistochemistry and used as surrogates to quantify drug effects. In summary, breast cancer tissue slices can be cultured in vitro as organotypic models. Nevertheless, although simple in concept, the delicacy of the model with regard to handling makes subsequent analytical processes challenging.

Original languageEnglish
Pages (from-to)253-255
Number of pages3
JournalJournal of Clinical Pathology
Volume66
Issue number3
Early online date16 Oct 2012
DOIs
Publication statusPublished - Mar 2013

Fingerprint

Breast Neoplasms
Immunohistochemistry
Tissue Preservation
Tamoxifen
Doxorubicin
Collagen
Animal Models
Biomarkers
Apoptosis
Cell Line
Pharmaceutical Preparations
In Vitro Techniques

Cite this

The practicalities of using tissue slices as preclinical organotypic breast cancer models. / Holliday, Deborah L.; Moss, Marcus A.; Pollock, Steven; Lane, Sally; Shaaban, Abeer M.; Millican-Slater, Rebecca; Nash, Claire; Hanby, Andrew M.; Speirs, Valerie.

In: Journal of Clinical Pathology, Vol. 66, No. 3, 03.2013, p. 253-255.

Research output: Contribution to journalArticle

Holliday, DL, Moss, MA, Pollock, S, Lane, S, Shaaban, AM, Millican-Slater, R, Nash, C, Hanby, AM & Speirs, V 2013, 'The practicalities of using tissue slices as preclinical organotypic breast cancer models', Journal of Clinical Pathology, vol. 66, no. 3, pp. 253-255. https://doi.org/10.1136/jclinpath-2012-201147
Holliday, Deborah L. ; Moss, Marcus A. ; Pollock, Steven ; Lane, Sally ; Shaaban, Abeer M. ; Millican-Slater, Rebecca ; Nash, Claire ; Hanby, Andrew M. ; Speirs, Valerie. / The practicalities of using tissue slices as preclinical organotypic breast cancer models. In: Journal of Clinical Pathology. 2013 ; Vol. 66, No. 3. pp. 253-255.
@article{2a050b0af2654c2c9fd6351385ccc937,
title = "The practicalities of using tissue slices as preclinical organotypic breast cancer models",
abstract = "Models considering breast cancer complexity cannot be easily or accurately replicated in routine cell line or animal models. We aimed to evaluate the practicality of organotypic tissue slice culture in breast cancer. Following ethical approval, 250 µm thick sections from surplus breast tumours (n=10) were prepared using a vibrating blade microtome. Triplicate tissue slices were placed in 6-well plates and cultured for up to 7 days ± tamoxifen (1 nM) or doxorubicin (1 µM). Tissue slices were fixed and embedded before sectioning for morphological evaluation and immunohistochemistry. H&E showed good preservation of tissue morphology. Collagen production was evident. Biomarkers of proliferation and apoptosis could be evaluated using immunohistochemistry and used as surrogates to quantify drug effects. In summary, breast cancer tissue slices can be cultured in vitro as organotypic models. Nevertheless, although simple in concept, the delicacy of the model with regard to handling makes subsequent analytical processes challenging.",
author = "Holliday, {Deborah L.} and Moss, {Marcus A.} and Steven Pollock and Sally Lane and Shaaban, {Abeer M.} and Rebecca Millican-Slater and Claire Nash and Hanby, {Andrew M.} and Valerie Speirs",
year = "2013",
month = "3",
doi = "10.1136/jclinpath-2012-201147",
language = "English",
volume = "66",
pages = "253--255",
journal = "Journal of Clinical Pathology",
issn = "0021-9746",
publisher = "BMJ Publishing Group",
number = "3",

}

TY - JOUR

T1 - The practicalities of using tissue slices as preclinical organotypic breast cancer models

AU - Holliday, Deborah L.

AU - Moss, Marcus A.

AU - Pollock, Steven

AU - Lane, Sally

AU - Shaaban, Abeer M.

AU - Millican-Slater, Rebecca

AU - Nash, Claire

AU - Hanby, Andrew M.

AU - Speirs, Valerie

PY - 2013/3

Y1 - 2013/3

N2 - Models considering breast cancer complexity cannot be easily or accurately replicated in routine cell line or animal models. We aimed to evaluate the practicality of organotypic tissue slice culture in breast cancer. Following ethical approval, 250 µm thick sections from surplus breast tumours (n=10) were prepared using a vibrating blade microtome. Triplicate tissue slices were placed in 6-well plates and cultured for up to 7 days ± tamoxifen (1 nM) or doxorubicin (1 µM). Tissue slices were fixed and embedded before sectioning for morphological evaluation and immunohistochemistry. H&E showed good preservation of tissue morphology. Collagen production was evident. Biomarkers of proliferation and apoptosis could be evaluated using immunohistochemistry and used as surrogates to quantify drug effects. In summary, breast cancer tissue slices can be cultured in vitro as organotypic models. Nevertheless, although simple in concept, the delicacy of the model with regard to handling makes subsequent analytical processes challenging.

AB - Models considering breast cancer complexity cannot be easily or accurately replicated in routine cell line or animal models. We aimed to evaluate the practicality of organotypic tissue slice culture in breast cancer. Following ethical approval, 250 µm thick sections from surplus breast tumours (n=10) were prepared using a vibrating blade microtome. Triplicate tissue slices were placed in 6-well plates and cultured for up to 7 days ± tamoxifen (1 nM) or doxorubicin (1 µM). Tissue slices were fixed and embedded before sectioning for morphological evaluation and immunohistochemistry. H&E showed good preservation of tissue morphology. Collagen production was evident. Biomarkers of proliferation and apoptosis could be evaluated using immunohistochemistry and used as surrogates to quantify drug effects. In summary, breast cancer tissue slices can be cultured in vitro as organotypic models. Nevertheless, although simple in concept, the delicacy of the model with regard to handling makes subsequent analytical processes challenging.

U2 - 10.1136/jclinpath-2012-201147

DO - 10.1136/jclinpath-2012-201147

M3 - Article

VL - 66

SP - 253

EP - 255

JO - Journal of Clinical Pathology

JF - Journal of Clinical Pathology

SN - 0021-9746

IS - 3

ER -